Fuda Cancer Hospital is considered one of the BEST cancer hospitals in China by patients and is affiliated to Jinan University and Translational Medicine Center Fuda Cancer Hospital South District and Fuda Cancer Hospital North District (collectively, “Fuda Cancer Hospital”) are located in Guangzhou, in the south of China. Both hospitals are modern and specialized cancer centers that are recognized for their minimally invasive therapies and innovative treatments that provide an effective alternative to the traditional treatment of chemotherapy/radiation/surgery. Fuda Cancer Hospital is affiliated with the Chinese Academy of Sciences’ Guangzhou Institute of Biomedicine and Health. The hospitals are teaching hospitals of Jinan University School of Medicine. In 2010, the central government designated the hospitals as nationally important clinics and awarded a five million RMB grant to them. The honorary president of the hospital is Academician Mengchao Wu, and the president is Professor Kecheng Xu, a renowned and highly respected specialist of general oncology and gastroenterology. Fuda Cancer Hospital focuses on the diagnosis and treatment of liver, lung, breast, nasopharyngeal, colorectal, uterus, stomach, esophageal, pancreatic, tongue, prostate, skin, larynx, and lymphoma cancers, as well as many others. The hospital insists on providing patient care and services and adopting an individualized approach in the treatment of patients based on their individual conditions. By combining conventional treatment with newly developed technologies and traditional Chinese medicine, the hospital is equipped to treat patients with a complete spectrum of available therapies, from the traditional to the cutting-edge. Besides the conventional treatments for cancer (surgery, chemotherapy and radiotherapy) the hospital has brought together innovative and proven new technologies such as Nano Knife Therapy, Interventional Hepasphere, cryosurgical ablation (CSA), vascular interventional therapy, Cancer Microvessel Intervention (CMI), photodynamic therapy, seed knife brachytherapy, radiofrequency ablation and bioimmunotherapy. The hospital prides itself on using a “3C+P” approach when treating patients: CSA, CMI, combined immunotherapy for cancer (CIC), and personalized therapy. So far, Fuda Cancer Hospital has performed more than 10,000 cases of cryosurgical ablation, and it performs the most number of cryosurgical ablations annually in the world. Dr. Franco Lugnani, the president of the International Society of Cryosurgery, has lauded Fuda for its efforts. Furthermore, the International Society of Cryosurgery designated the hospital as a training center for doctors from the Asian-Pacific region who are interested in cryosurgery. The hospital’s concept and diagnostic techniques have gained a great reputation from countries throughout southeast Asia, as well as the United States, the United Kingdom, Spain, Denmark, Netherlands, and other countries.
